AZD 6482 Catalog No.:M10943-2 and 191 ± 1 nM

and 191 ± 1 nM for KMS-11

UNC0638 reactivated G9a-silenced genes and a retroviral reporter gene in a concentration-dependent manner without promoting differentiation

InChi: InChI=1S/2C14H28O2

Acetazolamide

15(2)25)28-16(3)26/h12-13

AZD 6482 Catalog No.:M10943-2 and 191 ± 1 nMAZD6482 is a potent, selective and ATP competitive PI3K inhibitor (IC(50) 0. 01 m). AZD6482 inhibited insulin induced human adipocyte glucose uptake in vitro (IC(50) of 4. 4 m). This is the first human target validation for PI3K inhibition as anti platelet therapy showing a mild and generalized antiplatelet effect attenuating but not completely inhibiting multiple signaling pathways with an impressive separation towards primary hemostasis. AZD6482 at